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We analyzed how cells from tumors caused by mutations in either lgl or brat use matrix metalloproteinases (MMPs) to facilitate metastasis in
Drosophila. MMP1 accumulation is dramatically increased in lgl larval imaginal discs compared to both wild type and brat mutants. Removal of
Mmp1 gene activity in lgl brain tumor cells reduced their frequency of ovarian micro-metastases after transplantation; whereas, removal of Mmp1
gene activity in brat tumor cells had no such effect. Host ovaries showed increased Mmp1 gene expression in response to transplantation of brat
tumors but not of lgl tumors. Reduction of MMP activity in host ovaries by ectopic expression of TIMP significantly reduced both lgl and brat
metastases in that organ. These results highlight the mechanisms that lgl and brat tumor cells use to metastasize. Our interpretation of these data is
that secretion of MMP1 from lgl tumor cells facilitates their metastasis, while secretion of MMP1 from host ovaries facilitates brat tumor
metastasis. This study is the first demonstration that Drosophila tumors utilize MMP activity to metastasize.
© 2007 Published by Elsevier Inc.Keywords: Drosophila; Matrix metalloproteinase; Lethal giant larvae; Brain tumor; MetastasisIntroduction
Metastasis is the formation of secondary tumors in distant
sites of the body, leading to poor prognosis and poor chance of
patient survival. The process of metastasis consists of several
steps. First, tumor cells leave the primary tumor, move through
the basement membrane and migrate into the surrounding
stroma. The tumor cells then enter the vasculature, travel to
distant sites, leave the vasculature, migrate into new tissues, and
form secondary tumors (Geho et al., 2005; Woodhouse et al,
1997).
Understanding the factors involved in tumor cell metastasis
is complicated by contributions from host stroma, extracellular
matrix, and angiogenesis. Primary tumors recruit normal cells
into the tumor and stimulate angiogenesis to support the tumor
mass. Tumor cells also interact with the host environment by
releasing signals to the host cells that stimulate the surrounding
stroma to release pro-migratory factors that facilitate metastasis⁎ Corresponding author.
E-mail address: bio_cals@jhu.edu (A. Shearn).
0012-1606/$ - see front matter © 2007 Published by Elsevier Inc.
doi:10.1016/j.ydbio.2006.12.001(Allinen et al., 2004; Bowden et al., 1999; Fidler, 2002; Liotta
and Kohn, 2001). Knowing how host responses affect tumor
metastasis is important as a potential target for cancer therapy.
The host tissue is not under the same selective pressures as
tumor cells and less prone to genetic instability. This is
potentially advantageous as a therapy target because there is less
chance of adaptation to the therapy.
Proteases are released by both host cells and cancer cells,
altering the microenvironment of tumor cells (Airola and
Fusenig, 2000; Werb, 1997). Proteases facilitate migration by
degrading extracellular matrix and by cleaving signaling
molecules, other proteases, and proteins allowing for activation
of pro-migratory signals and inactivation of anti-migratory
signals (Andreason et al., 1997; Nakahara et al., 1997; Xu et al.,
2001). Matrix metalloproteinases (MMPs) are one class of
proteases that have been implicated in tumor progression. There
are over 24 MMPs identified in mammals; these fall into a
number of subgroups based on substrate specificity and protein
domains. Broadly, MMPs fall into two groups, soluble-secreted
proteases and membrane-bound proteases (reviewed by Stern-
licht and Werb, 2001). Increased expression of MMPs within
tumors has been positively correlated with the malignancy of
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cancer, and squamous cell carcinomas (MacDougall et al.,
1995; Murray et al., 1996; Yamamoto et al., 2004).
MMPs have been implicated in several stages of tumor
progression such as angiogenesis, proliferation, and metastasis.
Numerous studies have highlighted the importance of MMP
expression in both tumor cells and in host cells for tumor
progression (examples: Coussens et al., 2000; Hiratsuka et al.,
2002; Lynch and Matrisian, 2002; Sabeh et al., 2004; Sounni et
al., 2002). For example, host expression of MMP-9 has been
correlated with increased angiogenesis and proliferation of
transplanted tumors (Huang et al., 2002). Mice deficient for
MMP-7 as well as carrying a germline mutation in APC show
reduced benign intestinal tumors compared to mice carrying the
mutant APC alone (Wilson et al., 1997). Tumor cells
expressing MT1-MMP showed increased ability to grow and
migrate in a 3D matrigel assay compared to cells deficient for
MT1-MMP (Hotary et al., 2003). Some MMPs have been
shown to have conflicting effects on tumor progression.
Expression of MMP-12 in squamous cell carcinoma tumors
correlates with invasiveness while expression of MMP-12 in
macrophages generates angiostatin causing an inhibition of
angiogenesis in tumors (Kerkela et al., 2002; Dong et al., 1997;
Cornelius et al., 1998). The large number of MMPs and their
involvement in many stages of tumor progression make it
difficult to evaluate separate contributions of individual MMPs
at specific stages in tumor progression. Additionally, MMPs
can have different functions when expressed in tumor cells or
in host tissues.
Tissue Inhibitors of Matrix Metalloproteinases, TIMPs, are
endogenous inhibitors of MMP activity. In mammals, four
TIMPs have been identified that are capable of reversibly
binding to the catalytic site of MMPs and inhibiting activity
(Sternlicht and Werb, 2001). Each TIMP has distinct functions
and expression patterns in the body (Chirco et al., 2006).
Drosophila has only one TIMP; it has been shown to inhibit
MMP activity in vivo (Page-McCaw et al., 2003).
Drosophila has just two MMPs; they both contain all of the
hallmark domains of MMPs but do not appear orthologous to
specific mammalian MMPs. MMP1 is a soluble protease that is
required for larval trachea development and metamorphosis
during pupation (Page-McCaw et al., 2003). MMP1 is expressed
at low levels throughout development with increased expression
at the end of embryogenesis and during the pupal stage (Llano
et al., 2000; Page-M cCa w et al., 2003 ). MMP2 is membrane
bound by a p utative GPI anchor; it is requi red in tis sue histolys is
and metamor phosis in pupae (Llano et al., 2002; Page -McCaw
et al., 200 3). The lack of redunda ncy in Drosophi la Mmp genes
potentially allows for examination of their specific roles in
normal development and tumor progression.
Previously, our lab demonstrated differences in metastatic
properties of lgl and brat tumors (Beaucher et al., 2006). Loss
of either gene function results in morphologically similar
neoplastic brain tumors. We transplanted fragments of mutant
brains into adult hosts where the tumor cells proliferated and
filled the abdomen. This method allowed for independent
manipulation of the host and tumor genotypes. We assayed formicro-metastasis formation in the ovariole. The Drosophila
ovary consists of approximately 15 individual ovarioles that
consist of germ line stem cells at the apical tip and a series of
developing egg chambers, each containing an oocyte and
supporting nurse cells surrounded by follicle cells. The entire
ovary is surrounded by a peritoneal sheath of cells and each
ovariole is surrounded by an epithelial sheath of cells as well
as basement membranes that underlie the epithelial sheath
and also surround each egg chamber. Tumor cells must
actively cross two cell layers (peritoneal and epithelial sheaths)
as well as basement membranes to form micro-metastases in
ovarioles.
We determined the metastatic frequency as the percentage of
ovarioles containing micro-metastases. By this method, we
found that both lgl and brat tumor cells had similar frequencies
of micro-metastases. Differences became clear with serial
transplantation of tumor cells into hosts. Increased time in
hosts led to a significant increase in the frequency of lgl micro-
metastases while the frequency of brat micro-metastases
remained constant. Additional differences were shown in
expression of cell fate markers in the micro-metastases. Brain
tumors in lgl and brat mutant larvae arise through disruption of
asymmetric division in neuroblasts (Lee et al., 2006a;
Betschinger et al., 2006; Lee et al., 2006b). Despite their
seemingly similar origins, lgl and brat tumors have remarkably
different metastatic properties.
In this study, we continued our exploration of the differences
between lgl and brat metastatic properties. To start understand-
ing the mechanisms utilized by the tumor cells to alter their
microenvironment, we examined the contribution of MMPs to
metastasis. Our study demonstrates that MMP1 facilitates the
metastasis of both lgl and brat tumors. We found that Mmp1
expression in lgl tumor cells but not in brat tumor cells
facilitates metastasis. We reduced MMP activity in host ovaries
by ectopic expression of TIMP. This resulted in a decreased
frequency of micro-metastases by both lgl and brat tumors.
Host ovaries increase their level of Mmp1 expression in
response to brat but not lgl tumors. This suggests that brat
tumor cells stimulate host ovaries to secrete MMP1. We infer
that MMP1 facilitates metastasis both by lgl and brat tumor
cells but they utilize it from different sources. This study is the
first demonstration of any MMP involvement in Drosophila
tumor metastasis.
Experimental procedures
Fly stocks
Drosophila stocks were maintained at 25° on standard cornmeal, molasses,
yeast, and agar food containing tegosept and proprionic acid as mold inhibitors.
Stocks used for donors in invasion assay: yw67 armadillo-lacZ; lgl4 /y+CyO,
yw67; Df(2L)net62/y+CyO, yw67 armadillo-lacZ; lgl4 Mmp12/y+CyO, yw67; Df
(2L)net62Mmp1101/y+CyO. All lgl mutant and lglMmp1 double mutant larvae
were the progeny of crosses between these stocks and were identified by the y
mutant phenotype.
yw67 armadillo-lacZ; brat14/y+CyO, yw67; brat18/y+CyO, yw67 armadillo-
lacZ; brat14Mmp1101/y+CyO, yw67; brat18Mmp12/y+CyO. All brat mutant and
bratMmp1 double mutant larvae were the progeny of crosses between these
stocks and were identified by the y mutant phenotype.
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y1w1f 1.
Wild type hosts were the progeny of a cross between Canton-S females and
yw67 males. Female sterile hosts were the progeny of a cross between Canton-S
females and ovoD1v24 males.
Stocks used for ectopic TIMP expression: yw67; UAS-TIMP/ UAS-TIMP
(transgene on third chromosome), yw67; UAS-GFP/UAS-GFP (transgene on
third chromosome), Gal4 driver lines: yw67; c323a/ y+ CyO, yw67; btlGAL4/y+
TM3 Ser, yw67;ElavGAL4/ElavGal4.
Transplantation of larval brain fragments
Transplantations of larval brain fragments were performed as previously
described (Woodhouse et al., 1994). Due to the small size of lgl Mmp1 and brat
Mmp1 brains, whole brain lobes were injected into hosts unlike lgl and brat
brain lobes that were quartered first. LglMmp1 brain fragments were cultured in
wild type hosts for 12 days at 25°. BratMmp1 brain fragments were cultured for
10 days in wild type hosts at 25°. All brain fragments were cultured for 7 days at
25° when ovoD hosts were used.
Detection of micro-metastases within host ovaries
All of the mutant cells were marked with arm-LacZ to allow for detection
within adult hosts using an anti-βGal antibody. After tumor culturing, the adult
abdomens were opened ventrally to expose ovaries. Ovaries were kept within
the abdomen to prevent damage to the ovaries and ovariole loss. Host
abdomens were fixed for 30 min in 3.7% formaldehyde in PBS, rinsed in PBS,
washed 3×30 min PBS, then 3×30 min PBS+0.6% Triton-X-100 (PBT), then
30 min in antibody incubation buffer consisting of PBT, 0.3% BSA, and 0.5%
sheep serum. Samples were incubated overnight at 4 °C on a rocker with
primary antibodies diluted in incubation buffer. Samples were washed
3×30 min in PBT at RT. Secondary antibody incubation was performed
overnight at 4 °C then 3×30 min washes at RT. Samples were then incubated
with 5U/mL Phalloidin (Molecular probes) and DAPI in incubation buffer for
1 h at RT. Ovaries were dissected and ovarioles were separated onto a slide in
VectaShield mounting medium. All of the ovarioles from each host were
mounted together on single slides. Tumor cell presence within ovarioles was
detected using a Zeiss LSM 510 Meta microscope.
Primary antibody used: chicken anti-βGal 1:50 (Immunology Consultants
Laboratory). Secondary antibodies used: All secondary antibodies were used at a
concentration of 1:200. FITC conjugated goat anti-chicken (Immunology
consultants laboratory), TRITC conjugated rabbit anti-chicken (Sigma),
Rhodamine Phalloidin (Molecular Probes).
Statistical analysis
The G-test of independence as described in Sokal and Rohlf (1969) was
computed for the analysis of metastasis data. Student's t-test was performed on
all real-time RT PCR data, unpaired and with 4 degrees of freedom.
Immunofluorescence of larval brains
Third instar larvae were inverted and fixed for 15 min in 3.7% formaldehyde
in PBS, rinsed in PBS, washed 3×30 min PBS. Samples were then washed
3×30 min in PBT then 30 min in antibody incubation buffer described above.
Samples were incubated in primary antibody in incubation buffer overnight at 4°
on a shaker. Samples were rinsed in PBT then washed 3×30 min then incubated
in secondary antibody for 1 h at room temperature on a shaker. Samples were
washed 3×30 min in PBT then mounted in VectaShield mounting medium.
Primary antibody: anti-MMP1 mouse monoclonal described in (Page-McCaw et
al., 2003), secondary antibody: Alexa Fluor 488 goat anti-mouse (Molecular
Probes).
RNA isolation and reverse transcription of tissue samples
Fresh tissue was harvested from either larvae or adult Drosophila and put
into 250 μL of Trizol Reagent (Invitrogen 15596-026) in a sterile microfugetube. Ovaries harvested from adult hosts after incubation with tumor cells were
washed with PBS to remove loosely adhering tumor cells on the surface and
then were put into the Trizol reagent. Samples were ground with a pestle and
allowed to sit at room temperature (RT) for 5 min. 100 μL of chloroform was
added and samples were hand shaken for 15 s, incubated at RT for 2 min, then
centrifuged at top speed for 30 min at 4 °C. The aqueous phase was
transferred to a clean tube and 125 μL of isopropanol was added then allowed
to sit at RT for 10 min. The samples were spun at top speed for 30 min at RT
to pellet the RNA. The supernatants were removed, 500 μL 75% ethanol was
added to pellets then samples were centrifuged for 10 min at 4 °C. The pellets
were air dried for 5–10 min, then resuspended in 10 μL of TE and incubated
at 60 °C for 2 min. The amount of RNA was quantified by OD260 in a
spectrophotometer and the concentration was adjusted to 1 μg/μL.
RNA was reverse transcribed into cDNA using the BioRad iScript cDNA
synthesis kit (cat #170-8890) following the protocol included with the kit.
Real-time quantitative PCR of cDNA samples
All reactions were performed using a Bio-Rad iCycler with iQ Sybr green
master mix (Bio-Rad), 2 μL of cDNA, and each primer at a concentration of
0.2 μM. The PCR protocol was 95 °C for 3 min, then 40 cycles of 95 °C for
5 s, 57 °C for 10sec, then 72 °C for 20 s. A melt-curve analysis of each
reaction was performed starting at 55 °C and increasing temperature by 0.5 °C
every 10 s. The melt-curve analysis verified that only one PCR product was
made in each reaction. Primers used: Mmp1: GGCAGAGGCGGGTAGATAG,
TTCAGTGTTCATAGTCGTAGGC, Mmp2: CGCAGAGCACCCGTTCTT,
CTGTCCCTCCCACCCGAAG, RpL11A: CTTCATGGCATCCTCCTTGG,
CGGTATCTATGGTCTGGACTTC, GapDH: GTCGGGCTTGTAGGCATCC,
AGGCATCCACTCACTTGAAGG.
Calculation of relative gene expression
C t is the cycle when the fluorescence is appreciably above background and is
linear with the log of the starting copy number. To determine the relative expression
of a gene of interest (GOI) we calculated the number of cycles between when the
house keeping gene (HK) crossed the threshold (C t) and when the GOI crossed.
Because the expression of the HK gene should be unchanged in all samples, any
difference in the number of cycles between HKCt and GOICt should be due to a
change in the starting amount of the GOI. The number of cycles between HK and
GOI for wild type samples was normalized and had a relative expression of 1. The
experimental samples were then normalized in relation to the wild type samples. We
performed each experiment using 2 housekeeping genes Rpl11A and GapDH to
ensure that there was no change in expression of the HK in lgl or brat samples
compared to wild type. The results were from three independent experiments that
were averaged prior to normalization.
Results
Mmp1 accumulation is altered in lgl but not in brat mutant
larvae
We examined MMP1 accumulation in lgl and brat mutant
larvae compared to wild type to determine if there was any
misregulation of MMP1 in tumorous mutants. MMP1 protein
expression in the brains and imaginal discs of wild type and
brat mutant larvae is not detectable over background levels
by immunofluorescence; any signal seen is from adjacent
trachea which strongly expresses MMP1 during the larval stage
(Figs. 1A, C). By contrast, lgl mutant larvae showed a dramatic
increase in the amount of MMP1 protein present in the imaginal
discs, although MMP1 in the brain was not detected above
background (Fig. 1B).
We performed real-time RT PCR on the brains and eye discs
of wild type, lgl, and brat mutants to allow for sensitive
Fig. 1. MMP1 accumulation in larvae. Wild Type larval brain lobes (white
dashed lines) and eye discs (yellow dashed lines) have no detectable MMP1
protein by immunofluorescence (A). MMP1 protein accumulates (green) in lgl
eye discs (B) while MMP1 levels in brat brain lobes and discs are similar to wild
type (C). Mmp1 relative gene expression in eye discs and brains (D).
Table 1
Relative expression of Mmps in larval eye-antennal discs and brains
Tissue sample Gene
analyzed
Cycles between
Mmp C t and HK C t
Relative
expression
Wild type EAD Mmp1 8.93±0.42 1
lgl EAD Mmp1 5.70±1.04** 9.38
brat EAD Mmp1 8.50±0.46 1.35
Wild type brain Mmp1 8.93±0.06 1
lgl brain Mmp1 7.63±0.75* 2.46
brat brain Mmp1 9.93±1.86 −2
Wild type EAD Mmp2 7.8±0.98 1
lgl EAD Mmp2 6.3±0.98 2.8
brat EAD Mmp2 9.04±1.01 0.4
Wild type brain Mmp2 7.02±0.79 1
lgl brain Mmp2 7.28±0.59 0.84
brat brain Mmp2 8.76±0.76 0.3
*=significant (p≤0.05); **=highly significant (p≤0.01) as determined by
Student's t-test. All other values were not significantly different from wild type
as determined by Student's t-test.
EAD=eye-antennal disc, C t is the threshold cycle.
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accumulation of Mmp1 transcript in lgl brains was 2.46 fold
higher than in wild type while accumulation in lgl mutant eye-
antennal discs was increased 9.38 fold compared to wild type.
Brat mutant brains and eye-antennal discs showed no
significant change in Mmp1 transcript accumulation compared
to wild type samples (Fig. 1D, Table 1). The levels of Mmp2
mRNA in lgl and brat mutant brains and eye-antennal discs
were not significantly different than the levels in wild-type
brains and eye-antennal discs as determined by Student's t-test
(Table 1) so we focused our studies on Mmp1.
Mmp1 mutant larvae have small brains and imaginal discs due
to hypoxia
MMP research in mammals has indicated that MMPs are
involved in several stages of tumor progression. We wanted to
study MMP contribution specifically in metastasis. Mmp1
mutant larvae survive through third instar but are extremely
small compared to wild type raising the possibility that MMP1
affects cell proliferation (Figs. 2A, B). Any effect on cell
proliferation would hinder our ability to focus on MMP1
involvement in metastasis. Therefore we evaluated the cause of
the reduced size seen in Mmp1 mutant larvae. These mutant
larvae have severe tracheal defects and small imaginal discs and
brain lobes. Previous analysis of Mmp1 mutants indicated that
the larvae were under hypoxic conditions due to the tracheal
defect (Page-McCaw et al., 2003).
To determine whether the small brains and discs were due to
hypoxia-induced cell cycle arrest we used tissue specific
expression of TIMP, an inhibitor of MMP activity. Previous
work showed that ubiquitous TIMP misexpression phenocopies
the loss of Mmp1 function phenotype (Page-McCaw et al.,2003). Larvae expressing TIMP in the trachea using a breathless
GAL4 driver should have reduced MMP activity in the trachea
but normal levels of MMP activity in the brains and imaginal
discs. We observed that expression of TIMP with the breathless
GAL4 driver caused tracheal defects like those seen in Mmp1
mutants resulting in larvae smaller than sibling controls.
Significantly, the brains and discs were reduced in size as
well (Fig. 2C). As a negative control for this experiment, we
used ElavGAL4 to express TIMP in brains and discs to reduce
the level of MMP activity and assay for brain and disc size.
ElavGAL4 would be expected to accumulate in differentiating
neuronal cell of brains and discs but not in trachea. Indeed,
expression of TIMP with ElavGAL4 did not affect larval size or
tracheal development. Dissection of the larvae revealed that the
brains and discs were the same size as wild type (Fig. 2D). A
caveat to this control, however, is that ElavGAL4 accumulates
in differentiating neuronal cell of brains and discs and may not
have accumulated early enough in development to affect brain
and disc cell proliferation.
Nevertheless, we interpret these data as indicating that the
reduced organ size seen in Mmp1 mutants was a secondary
result of the tracheal defects and not due to a direct affect of
Mmp1 on brain and disc growth. This interpretation is supported
by experiments described below showing that both lglMmp1
and bratMmp1 double mutant brains grow like lgl and brat
mutant brains when transplanted into adult hosts.
Mmp1 is required in the tumor cell for metastasis of lgl tumors
We generated fly lines that were mutant for both lgl and
Mmp1. As were Mmp1 larvae, the lglMmp1 larvae were
extremely small and had reduced brain lobes and discs. We
transplanted fragments of mutant brains into adult hosts that had
rudimentary ovaries (ovoD) and allowed them 12 days for
proliferation. Qualitatively, lgl Mmp1 tumor cells proliferated
as well as lgl tumor cells in host abdomens. Dissection of the
abdomens revealed the host's guts and an abundance of tumor
cells (Figs. 3A, B). Previously, we demonstrated these cells
Fig. 2. Removal of MMP1 activity causes larval hypoxia resulting in reduced brain lobe size. Wild type third instar larva and dissected brain (A) compared to Mmp1
mutant larva with tracheal defects (arrow) resulting in small body and brain size (B). TIMP expression in trachea results in tracheal defect (arrow) as well as small body
and brain size (C). Expression of TIMP in the brain resulted in normal sized larva and brain with no tracheal defect (D).
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reporter gene (Woodhouse et al., 1994).
To study the affect of removingMmp1 activity on metastasis,
mutant larvae were marked with arm-LacZ that is expressed in
all cells. This allows for detection of micro-metastases within
host ovaries by immunofluorescence using an anti-βGal
antibody. Metastatic frequency was determined by the percent
of ovarioles with at least one micro-metastasis. We previously
showed that lgl tumor cells are able to invade 15.8% of the
ovarioles analyzed (58/367) after 12 days of proliferation in the
hosts (Beaucher et al., 2006). Here, we transplanted brainFig. 3. lgl Mmp1 and brat Mmp1 tumor cells proliferate as well as lgl and brat cell
proliferated when transplanted into an adult ovoD female. The abdomen was dissecte
reduced in size (B) but proliferated when transplanted into an adult ovoD host (B′). Br
an adult ovoD host (C′). Brat Mmp1 larval brain lobes were reduced (D) in size bufragments from lglMmp1 larvae into wild type hosts. After
12 days of culturing, only 4% of the ovarioles had micro-
metastases (7/175), a dramatic reduction compared to lgl
tumors (Fig. 4C, Table 2). This demonstrates that Mmp1 gene
activity in tumor cells facilitates lgl metastasis. The lglMmp1
micro-metastases that did form were similar in size and shape to
lgl micro-metastases establishing that the reduced metastatic
frequency was not a result of a failure to proliferate in ovarioles
(Figs. 4A, B).
LglMmp1 brains were significantly smaller than lgl brains
resulting in smaller brain fragments being injected. To ensures in a transplantation assay. 10-day-old lgl larval brain lobes overgrew (A) and
d and tumor cells outlined in white dashed lines (A′). lgl Mmp1 brain lobes were
at larval brain lobes were overgrown (C) and proliferated when transplanted into
t proliferated when transplanted into an adult ovoD host (D′).
Fig. 4. Removal of Mmp1 gene activity from tumor cells reduces lgl metastasis but not brat metastasis. Lgl micro-metastases (arrow) within the host ovariole (A) are
similar in size to lgl Mmp1 micro-metastases (B). Lgl Mmp1 tumor metastatic frequency was significantly reduced compared to lgl tumors (C). Brat tumor cells form
micro-metastases (D) that are of similar size as brat Mmp1 (E) and there is no difference in metastatic frequency (F). Tumor cells were marked with arm-LacZ and
detected with an anti-βGal antibody in green, Ovariole Epithelial sheath visualized with Rhodamine Phalloidin in red, DAPI in blue. *pV0.05, **pV0.01 †Metastatic
frequencies of lgl and brat tumors were previously reported (submitted).
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we endeavored to standardize the amount of tissue injected. We
transplanted lglMmp1 brain fragments into female sterile hosts
that had rudimentary ovaries (ovoD hosts) and cultured the
tumor cells for 7 days. The lack of ovaries in these hosts allowed
for easy harvesting of tumorous tissue from the hosts'
abdomens. Equal amounts of lgl and lglMmp1 tumor cells
were retransplanted into wild type hosts for analysis of
metastatic frequency. The tumor cells proliferated for 12 days
in the secondary hosts and then the ovaries were analyzed forTable 2
Ovarioles with micrometastases after incubation with tumor cells
Donor
genotype
Host genotype Days of
incubation
Invaded/
total
% invasion
lgl Wildtype 12 58/367 15.8
Wt 19 87/366 23.8
UAS-GFP/c323a 19 11/100 11
UAS-TIMP/c323a 19 1/121 0.8
lglmmp1 Wt 12 7/175 4
Wt 19 38/372 10.2
brat Wt 10 61/406 15
Wt 17 80/391 20.5
UAS-GFP/c323a 17 29/142 20.4
UAS-TIMP/c323a 17 3/87 3.4
bratmmp1 Wt 10 26/195 13.3
Wt 17 24/176 13.6micro-metastasis formation. As we previously reported, lgl
tumors showed an increase in metastasis after the prolonged
incubation with 23.8% of the ovarioles containing micro-
metastases (87/366) compared to 15.8% after incubation in one
host. The lglMmp1 tumors also showed an increase in
metastasis after prolonged incubation with 10.2% of the
ovarioles containing metastases (38/372) compared to 4%
after incubation in one host. While the frequency of ovarioles
with lglMmp1 micro-metastases increased with time, it is still
significantly lower than the metastatic frequency of lgl tumors
after the same amount of incubation time (Fig. 4C, Table 2).
Mmp1 is not required in the tumor cell for brat metastasis
As with lgl, we generated fly lines that were mutant for brat
andMmp1. The tracheal defect and reduced brain size were also
present in these double mutant larvae. After transplantation, the
bratMmp1 tumor cells proliferated as well as brat tumor cells in
the adult hosts (Figs. 3C, D). We then examined the effect of
removing Mmp1 gene activity on brat tumor metastasis. We
previously reported (Beaucher et al., 2006) that brat tumor cells
form micro-metastases in 15% of the ovarioles examined after
10 days of incubation (61/406). BratMmp1 brain fragments
transplanted into hosts formed micro-metastases in 13.3% of the
ovarioles examined (Fig. 4F, Table 2). This was not a significant
reduction in metastatic frequency. The bratMmp1 micro-
metastases (Fig. 4E) were similar in size and shape compared
Fig. 5. TIMP expression in the host ovary dramatically reduces both lgl and brat micrometastasis formation. Lgl micro-metastases (A) and brat micro-metastases (B)
develop in ovarioles expressing GFP by an ovary specific driver. The lgl (C) and brat (D) micro-metastases in TIMP expressing ovaries are able to form within the
epithelial sheath. The expression of TIMP in the ovary significantly reduced the rate of metastasis for both lgl and brat tumor cells compared to hosts expressing GFP
(E). Tumor in green, Epithelial sheath in red, DAPI in blue. Relative Mmp1 expression in host ovaries exposed to brat tumors is significantly higher than uninjected
hosts and hosts exposed to lgl tumors (F). The expression of mmp2 is slightly increased in host ovaries exposed to brat tumors compared to uninjected or lgl injected
hosts. *p≥0.05.
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ovarioles.
As with the lgl and lglMmp1 mutants, we determined if the
unequal brain size between the mutants affected metastatic rate
in any way. We transplanted brat and bratMmp1 brains into
female sterile hosts and incubated for 7 days then retransplanted
the tumor cells into wild type hosts and incubated for 10 days.
We previously found that brat tumor cells transplanted into
secondary hosts formed micro-metastases in 20.5% of ovarioles
examined (80/391) which is not a significant increase in
metastasis compared to the frequency of 15% seen after 10 days
of culturing in primary hosts. BratMmp1 tumor cells formed
micro-metastases in 13.6% of the ovarioles examined (Fig. 4,
Table 2) after prolonged culture which was not significantly
different from the metastasis frequency of 13.3% seen after
10 days of culturing in one host. Even with prolonged culturing
in two hosts, there was not a significant difference in metastatic
rate between brat and brat Mmp1 tumors. Therefore, Mmp1
activity in the tumor cell does not facilitate brat tumor
metastasis.
Host expression of MMP1 is required for metastasis
Tumor cells can act directly on the microenvironment to
facilitate metastasis and indirectly by inducing host cell
responses. We determined if metastasis was facilitated by
MMPs secreted by host ovaries in response to tumor cells.
Because Mmp1 mutants die as late larvae/early pupae we could
not use these flies as hosts. To remove MMP activity in hosts,
we used an ovary specific GAL4 driver, c323a, to express UAS-
TIMP in the host ovaries. The driver expresses strongly in thelate stage follicle cells and weakly throughout the ovary. This
was determined by the pattern of UAS-GFP accumulation in
response to this driver (data not shown). In addition to driving
expression in ovaries, c323a also drives expression in the gut
during larval development. The larval expression of TIMP by
the c323a driver is lethal in larvae raised at 25° (unpublished
observation). To prevent larval lethality, UAS-TIMP/c323a
larvae and control reporter UAS-GFP/c323a larvae were raised
at 17° to reduce GAL4 expression. Once the flies enclosed, the
UAS-TIMP/c323a and UAS-GFP/c323a flies were shifted to
25° 2 days prior to transplantation of tumor cells. This allowed
us to express TIMP or GFP in the adult ovary without the larval
tracheal defect and lethality seen with expression of TIMP by
the c323a driver at room temperature.
We transplanted brain tissue into female sterile hosts for
7 days then retransplanted into either reporter or TIMP
expressing hosts. This ensured that the same tumor cell
population was being injected into both host types. Trans-
planted lgl tumor cells formed micro-metastases in reporter
expressing hosts in 11% of the ovarioles analyzed (Figs. 5A, E,
Table 2). The lgl tumor cells transplanted in TIMP expressing
hosts only formed micro-metastases in 0.8% of the ovarioles
analyzed (Figs. 5C, E, Table 2). This was a significant reduction
in the metastatic rate of lgl tumors.
Brat tumor cells transplanted into reporter hosts were able to
form micro-metastases in 17% of the ovarioles analyzed (Figs.
5B, E, Table 2). The rate of metastasis was significantly lower in
TIMP expressing hosts with 3.4% of the ovarioles containing
micro-metastases (Figs. 5D, E, Table 2). Thus, expression of
TIMP in host ovaries reduced the metastatic frequency of both
lgl and brat tumors.
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increase in Mmp1 gene expression
We showed above that inhibiting MMP activity in the host
caused a drastic reduction in both lgl and brat metastatic ability.
Research in mammals has shown that host stroma can increase
expression of MMPs in response to tumors, facilitating
invasion. We looked to see if a similar induction of MMPs is
seen in host ovaries after exposure to tumors. We performed
real-time RT PCR on ovaries dissected from wild type hosts that
had been transplanted with either lgl or brat tissue and
compared to ovaries from untransplanted hosts. We looked for
changes in expression of both Mmp1 and Mmp2 (Table 3).
Mmp1 expression was not significantly changed in ovaries
exposed to lgl compared to untransplanted hosts. Ovaries
exposed to brat tissue showed a 21.9 fold increase in Mmp1
expression. Expression of Mmp2 was unchanged in response to
lgl tumors and increased 3.1 fold in response to brat tumor
cells. Although, the ovaries dissected from these hosts
contained micro-metastases, we do not believe that the presence
of these tumor cells contributed significantly to these data. Only
15–20% of the ovarioles in these ovaries contained micro-
metastases; we estimate that each micro-metastasis contains on
average 20 cells. If 20% of the 15 ovarioles in an ovary have
micro-metastases, that would be 3 micro-metastases per ovary.
Each ovary on average would only have 60 tumor cells (3
micrometastases ×20 cells) compared to the tens of thousands of
cells that make up an ovary. It is unlikely that the level ofMmp1
or Mmp2 transcript in these 60 cells, even if dramatically
elevated, could significantly affect the level of transcript we
measure in total ovaries. However, further investigation is
required to determine which cells in the ovary are upregulating
Mmp1 in response to exposure to brat tumors.
Discussion
MMP1 requirement in tumor cells
Upregulation of MMP1 is part of the lgl larval tumor
phenotype. Lgl mutant eye-antennal discs and brains showed an
increase in Mmp1 transcription as well as protein expression
compared to wild type. Removal of Mmp1 gene expression
from lgl mutants dramatically decreased the metastatic ability
of the tumor cells demonstrating a role for mmp1 in facilitatingTable 3
Relative expression of Mmp1 and Mmp2 in host ovaries
Tissue sample GOI Cycles between
GOI C t and HK C t
Relative
expression
Uninjected host ovary Mmp1 11.64±1.83 1
lgl injected host ovary Mmp1 10.10±1.28 2.9
brat injected host ovary Mmp1 7.19±1.86* 21.9
Uninjected host ovary Mmp2 9.31±0.78 1
lgl injected host ovary Mmp2 8.92±0.80 1.3
brat injected host ovary Mmp2 7.66±0.91* 3.1
*pV0.05 as determined by Student's t-test of independence, all other values
were not significantly different from uninjected ovary values.
GOI=gene of interest; HK=housekeeping gene; C t = threshold cycle.the metastasis of lgl tumor cells. The decrease was not due to
the difference in size of the brain fragments transplanted since a
significant decrease was still observed after standardizing the
amount of tissue transplanted by serial transplantation. Our
previous results showed that the rate of lgl tumor metastasis
increased with serial passaging. We observed the same result
here with lglMmp1 tumors indicating that the factors involved
in the increased metastasis with serial passaging were not
Mmp1 dependent.
Brat mutant larvae had no alterations in Mmp1 transcript
accumulation in the brain or eye disc compared to wild type.
Removal of Mmp1 from brat tumors had no significant effect
on metastasis. Serial transplantation did not significantly alter
the metastatic rate of either brat or bratMmp1 tumor cells.
These results demonstrate that in brat tumorsMmp1 expression
in the tumor cells themselves does not facilitate metastasis.
Our previous work found dramatic differences in metastatic
properties between lgl and brat tumors. The results presented
here are further examples of the different mechanisms used by
these tumors to undergo metastasis. Our data suggest that
metastasis is a phenotype that can be achieved by multiple
mechanisms. Lgl tumor cells require Mmp1 activity from the
tumor cell to facilitate metastasis while brat tumor cells do not.
How MMP1 alters the microenvironment to facilitate lgl
metastasis is unknown. MMP1 is capable of degrading type IV
collagen in vitro but in vivo specificity for MMP1 activity is
currently unknown. Type IV collagen is a primary component
of the extracellular matrix in Drosophila and MMP1 from the
tumor cell may facilitate metastasis by cleaving ECM and
allowing tumor cells to pass. Alternatively, MMP1 may
facilitate metastasis by activating pro-migratory factors or
inhibiting anti-migratory factors in the tumor microenviron-
ment. Mammalian work found that MMPs cleave receptors on
cell surfaces, other proteases, factors contained within the
ECM, and other proteins (reviewed by Sternlicht and Werb,
2001).
MMP1 expression in the host
Work in mammalian metastasis has highlighted the impor-
tance of the tumor microenvironment. Tumor cells use similar
mechanisms and signaling pathways as are utilized by cells
during normal physiological invasion. They stimulate the
surrounding host stroma to release promigratory signals. One
response of host cells to tumor signals is the secretion of MMPs
and other proteases that break down the ECM, facilitating the
invasion of metastatic cells.
We removed MMP activity from the tumor microenviron-
ment by expressing the inhibitor TIMP in the host ovaries. lgl
tumor metastasis was almost completely inhibited with the
removal of MMP activity in the host ovary. TIMP is a secreted
protein, so TIMP expression in the ovary would be expected to
inhibit MMPs secreted both by host tissue and tumor cells. This
makes it difficult to determine if the reduced metastasis was due
to inhibition of host or tumor cell MMPs. Most likely, the
reduction in lgl metastasis seen is due to the removal of MMP
activity derived from the tumor cells. This inference is based on
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ovaries after exposure to lgl tumors as well as the dramatic
results seen with the removal of Mmp1 from the lgl tumor cells.
Removal of Mmp1 from brat tumor cells did not alter
metastatic ability. However, TIMP expression in host ovaries
did significantly reduce brat micro-metastasis formation. These
data coupled with the data showing a 21.9 fold increase in
Mmp1 mRNA accumulation in host ovaries after exposure to
brat tumor cells suggest that brat utilizes MMP1 from the
host to facilitate metastasis. How brat tumor cells induce the
expression of Mmp1 in the host ovary is unknown. The
requirement for MMP1 activity from the host could explain the
lack of increase in frequency of brat micro-metastases with
serial passaging of tumor cells. The ovaries in each host
transplanted with brat tumors would start out with a low level
of MMP1 secretion. That level would increase with time.
However, the new host transplanted with tumor cells from the
previous host would again start out with a low level of MMP1
secretion.
Mutations in lgl and brat cause tumors that are superficially
similar, yet the metastatic characteristics of each are very
different. In wild type larval brains, neuroblasts divide
asymmetrically to produce a neuroblast and a ganglion mother
cell (GMC) which will then divide once more to produce 2
daughter cells. Recently, it was shown that lgl mutant brains
overgrow due to symmetric division of neuroblasts (Lee et al.,
2006a). Some of the neuroblasts in lgl mutant brains do divide
asymmetrically, the resulting GMC appears to differentiate
normally. Brat mutant larval brains also have overproliferation
of neuroblasts (Betschinger et al., 2006; Lee et al., 2006b). In
brat brains, neuroblasts divide asymmetrically but the resulting
GMCs do not down regulate neuroblast markers. Some of these
aberrant GMCs differentiate but most expand in size and reenter
the cell cycle producing more neuroblasts. The differences in
how these tumors originate must account for their different
metastatic properties. We show in this study that lgl tumors rely
primarily on secreted MMP1 from the tumor cells while brat
tumors appear to induce MMP1 expression from the host to
facilitate metastasis. The tumors require the same protein but
from different sources and for potentially different purposes.
Alternative mechanisms of metastasis could explain why
histologically similar human tumors might respond differently
to radiation and drug treatments. We have started to understand
the underlying mechanisms in two morphologically similar
Drosophila tumors. There are mutations in other genes that
affect asymmetric neuroblast division and cause brain tissue to
overproliferate after transplantation in adult hosts (Caussinus
and Gonzalez, 2005). Analysis of metastatic characteristics
from tumors generated by these mutations will allow for a better
understanding of the different possible mechanisms used.
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